Caricamento...

Drug-induced immune-mediated thrombocytopenia secondary to sunitinib in a patient with metastatic renal cell carcinoma: a case report

INTRODUCTION: Sunitinib is an oral multi-targeted tyrosine kinase inhibitor approved for first line treatment for metastatic renal cell carcinoma and imatinib-resistant metastatic gastrointestinal stromal tumors. Sunitinib administration can cause myelosuppression resulting in neutropenia and thromb...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Ansari, Zia, George, Mathew K
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2013
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3599754/
https://ncbi.nlm.nih.gov/pubmed/23442444
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1752-1947-7-54
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !